Suppr超能文献

基于蛋白质模板的铜纳米簇用于人血清白蛋白的荧光测定。

Protein-templated copper nanoclusters for fluorimetric determination of human serum albumin.

机构信息

Department of Chemistry "Ugo Schiff", University of Florence, 50019, Sesto Fiorentino, FI, Italy.

出版信息

Mikrochim Acta. 2021 Mar 8;188(4):116. doi: 10.1007/s00604-021-04764-7.

Abstract

Copper nanoclusters (CuNCs) are attractive for their unique optical properties, providing sensitive fluorescent detection of several kinds of targets even in complex matrices. Their ability in growing on suitable protein and nucleic acid templates make CuNCs efficient optical reporters to be exploited in bioanalysis. In this work, we report the specific and sensitive determination of human serum albumin (HSA) in human serum (HS) and urine via CuNCs fluorescence. HSA is the most abundant protein in plasma, and plays a key role in the early diagnosis of serious pathological conditions such as albuminuria and albuminemia. Recently, HSA has become clinically central also as a biomarker to assess severity, progression, and prognosis of various cancers. We report the controlled and reproducible growth of CuNCs directly on the target analyte, HSA, which results in a fine dose-dependent fluorescent emission at 405 nm. The protocol is optimized in water, and then applied to serum and urine specimens, without matrix pretreatment. The method linearly responds within the whole concentration of clinical interest, with a sensitivity of 1.8 ± 0.1 × 10 g L and 0.62 ± 0.03 × 10 g L in serum and urine, respectively, and excellent reproducibility (CV% ca. 3% for both). The assay is designed to have a single protocol working for both matrices, with recovery of 95% (HS) and 96% (urine). The stability of the fluorescence after CuNCs formation was tested over 3 days, displaying good results (yet higher in urine than in serum).

摘要

铜纳米簇 (CuNCs) 因其独特的光学性质而备受关注,即使在复杂基质中,它们也能提供对多种目标物的灵敏荧光检测。其在合适的蛋白质和核酸模板上生长的能力使其成为生物分析中高效的光学报告物。在这项工作中,我们报告了通过 CuNCs 荧光对人血清白蛋白 (HSA) 在人血清 (HS) 和尿液中的特异性和灵敏测定。HSA 是血浆中最丰富的蛋白质,在白蛋白尿和白蛋白血症等严重病理状况的早期诊断中起着关键作用。最近,HSA 也成为评估各种癌症严重程度、进展和预后的临床中心标志物。我们报告了 CuNCs 在目标分析物 HSA 上的可控和可重现生长,这导致在 405nm 处产生精细的剂量依赖性荧光发射。该方案在水中进行优化,然后应用于血清和尿液标本,无需基质预处理。该方法在线性范围内响应整个临床感兴趣的浓度,在血清和尿液中的灵敏度分别为 1.8±0.1×10g L 和 0.62±0.03×10g L,具有出色的重现性(CV% 约为 3%)。该测定设计有一个适用于两种基质的单一方案,回收率为 95%(HS)和 96%(尿液)。测试了 CuNCs 形成后荧光的稳定性,结果良好(尿液中的稳定性高于血清)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcde/7940276/12fa16d27706/604_2021_4764_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验